The head and neck cancer immune landscape and its immunotherapeutic implications-Reference-Cited by-同舟云学术

The head and neck cancer immune landscape and its immunotherapeutic implications

Published:2016-10-20 Issue:17 Volume:1 Page:
ISSN:2379-3708
Container-title:JCI Insight
language:en
Short-container-title:

Author:

Mandal Rajarsi,Şenbabaoğlu Yasin,Desrichard Alexis,Havel Jonathan J.,Dalin Martin G.,Riaz Nadeem,Lee Ken-Wing,Ganly Ian,Hakimi A. Ari,Chan Timothy A.,Morris Luc G.T.

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Reference81 articles.

1. Safety and Tumor Responses with Lambrolizumab (Anti–PD-1) in Melanoma

2. Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

3. Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients

4. PD-1 blockade induces responses by inhibiting adaptive immune resistance

5. PD-1 as an emerging therapeutic target in renal cell carcinoma: current evidence;Tykodi;Onco Targets Ther,2014

Cited by 580 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Digital Spatial Profiling identifies distinct patterns of immuno-oncology-related gene expression within oropharyngeal tumours in relation to HPV and p16 status;Frontiers in Oncology;2024-09-12

2. Divergent response to radio-immunotherapy is defined by intrinsic features of the tumor microenvironment;2024-09-10

3. Inhibition of ADAM17 increases the cytotoxic effect of cisplatin in cervical spheroids and organoids;Frontiers in Oncology;2024-09-02

4. Tumor-derived extracellular vesicles in the immune microenvironment of head and neck squamous cell carcinoma: Foe or future?;Journal of Stomatology, Oral and Maxillofacial Surgery;2024-09

5. The interplay between persistent pathogen infections with tumor microenvironment and immunotherapy in cancer;Cancer Medicine;2024-09